20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T24141 | HIV-1 Inhibitor 18A | HIV-1 Inhibitor-18A | HIV Protease |
HIV-1 Inhibitor 18A (HIV-1 Inhibitor-18A) specifically inhibits the entry of multiple HIV-1 isolates. | |||
TP1149 | HIV-1 Rev (34-50) | HIV-1 Rev 34-50,HIV-1 rev Protein (34-50) | HIV Protease |
HIV-1 Rev (34-50) (HIV-1 rev Protein (34-50)) is a 17 amino acid peptide with anti-HIV-1 activity. HIV-1 Rev (34-50) is derived from the Rev-responsive element-binding domains of Rev in HIV-1. | |||
T67833 | HIV-1 inhibitor-54 | HIV Protease | |
HIV-1 inhibitor-54 is a potent HIV-1 inhibitor showing anti-HIV activity (EC50 : 32 nM) against WT HIV-1 (strain IIIB) x in MT-4 cells.HIV-1 inhibitor-54 can be used to study viral infections. | |||
T9039 | HIV-1 Nef-IN-1 | HIV Protease | |
HIV-1 Nef-IN-1 is an inhibitor of HIV-1 Nef protein. It efficiently competes for Nef-SH3Hck interactions(Kd : 6.7 μM). | |||
T9854 | HIV-1 inhibitor-6 | 3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- | HIV Protease |
HIV-1 inhibitor-6 (3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo-) is a potent HIV-1 pre-mRNA selective splicing inhibitor that blocks HIV replication. | |||
T61793 | HIV-IN-6 | HIV Protease | |
HIV-IN-6 is an HIV viral inhibitor that inhibits the replication of the HIV virus.HIV-IN-6 has anti-HIV viral activity and works by targeting Src family kinases (SFK) (e.g., Hck) that interact with the viral Nef protein. | |||
T60742 | HIV-1 integrase inhibitor 8 | HIV Protease | |
HIV-1 integrase inhibitor 8 is an inhibitor of HIV-1 integrase. Integration is a required step in HIV replication [1]. | |||
TP1637 | HIV gag peptide (197-205) | HIV gag peptide 197-205 | |
HIV gag peptide (197-205) is a H-2Kd-restricted epitope derived from the p24 portion of the HIV-1 gag protein and composed of the amino acid 197-205 (AMQMLKETI). | |||
TP1674 | HIV p17 Gag (77-85) | HIV p17 Gag 77-85 | |
HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by in... | |||
T40719 | (Cys47)-HIV-1 tat Protein (47-57) | (Cys47)-HIV-1 tat Protein (47-57) | |
(Cys47)-HIV-1 tat Protein (47-57) possesses membrane translocation functionality and can serve as a surface derivatization agent for magnetic pharmaceuticals, thereby enhancing their uptake into specific target cells. | |||
T39729 | HIV Protease Substrate 1 | ||
HIV Protease Substrate 1 is a fluorogenic compound that offers insights into the enzymatic activity of HIV protease, making it a valuable tool for studying this aspect. | |||
TP1743 | MPG, HIV related | ||
MPG, a 27-amino acid peptide compound, is derived from the fusion peptide domain of HIV-1 gp41 and the nuclear localisation sequence of SV40 large T antigen. As a potent delivery agent, MPG enables efficient and widespre... | |||
T11564 | HIV-1 inhibitor-3 | Others | |
HIV-1 inhibitor-3 is an HIV infection inhibitor. | |||
T11566 | HIV-1 integrase inhibitor | Others | |
Hiv-1 integrase inhibitor is an effective anti-HIV drug. | |||
TP1776 | HIV-1 TAT 48-60 | ||
HIV-1 TAT (48-60) is a cell-penetrating peptide derived from the human immunodeficient virus (HIV)-1 Tat protein residue 48-60. This is one of the cell-penetrating peptides generated from the human immunodeficient virus ... | |||
T11565 | HIV-1 integrase inhibitor 7 | Others | |
HIV-1 integrase inhibitor 7 is a potent HIV-1 integrase inhibitor (IC50: 33.3 nM). | |||
T11568 | HIV-1 integrase inhibitor 4 | Others | |
HIV-1 integrase inhibitor 4 is an HIV-1 integrase strand transfer (INST) inhibitor (IC50: 3.7 nM). | |||
T11567 | HIV-1 integrase inhibitor 3 | Others | |
HIV-1 integrase inhibitor 3 is an HIV-1 integrase strand transfer (INST) inhibitor (IC50: 2.7 nM). | |||
T76502 | HIV-1, HIV-2 Protease Substrate | ||
HIV-1, HIV-2 Protease Substrate is a compound serving as the substrate for the proteases of both HIV-1 and HIV-2, featuring four residues that allow for conservative substitutions at the substrate binding sites of these ... | |||
T74282 | HIV-IN-2 | ||
HIV-IN-2 (Compound 100) is a potent inhibitor of HIV, showing potential for research into HIV infection [1]. |